Attached files

file filename
EX-99.2 - SLIDES SUMMARIZING THIRD QUARTER FINANCIAL RESULTS - Xylem Inc.d429180dex992.htm
8-K - FORM 8-K - Xylem Inc.d429180d8k.htm

Exhibit 99.1

 

LOGO

Xylem

1133 Westchester Ave., White Plains, NY 10604

Tel +1.914.323.5700 Fax +1.914.696.2960

FOR IMMEDIATE RELEASE

 

Contacts:  

Media

Tom Glover

+1-914-323-5891

Tom.Glover@xyleminc.com

 

Investors

Phil De Sousa

+1-914-323-5930

Phil.DeSousa@xyleminc.com

Xylem Inc. reports third quarter 2012 results

Third quarter adjusted net income was $83 million or $0.44 per share; $72 million or $0.38 per share as reported

Third quarter revenue up 3 percent in constant currencies to $931 million; down 1 percent as reported on negative impact of currency translation; emerging market revenue up 9 percent in constant currencies

Gross margin climbs 130 basis points to 40.2 percent as Customer Excellence and cost reduction initiatives drive profitability; adjusted operating margin was 12.9 percent

Company completes second acquisition in 2012 with the purchase of Heartland Pump, bolstering industrial dewatering portfolio

WHITE PLAINS, N.Y., November 1, 2012 – Xylem Inc. (NYSE: XYL), a leading global water technology company focused on solving the world’s most challenging water issues, today reported third quarter revenue of $931 million, up 3 percent on a constant currency basis, down 1 percent as reported from the third quarter 2011. Third quarter net income was $72 million or $0.38 per share, down $0.04 per share from the same period last year. Adjusting for one-time separation costs resulting from the Xylem spinoff from ITT Corporation on October 31, 2011, and special items, net income was $83 million or $0.44 per share, down $0.01 per share over the third quarter 2011 on a normalized basis.*

“As we mark our first anniversary as a stand-alone water company, our performance showcases both the strength of our global portfolio, with 9 percent constant currency revenue growth in the emerging markets, and our strategic focus on margin expansion through the execution of our Customer Excellence sales initiative and cost discipline,” said Gretchen McClain, President and Chief Executive Officer of Xylem. “We’re also seeing the benefit of our investments in acquisitions. Just last week we completed the purchase of Heartland Pump, which expands our

 

* The 2011 normalized earnings per share reflect adjustments (including interest expense, stand-alone costs, and special tax items) to our GAAP results to better illustrate year-over-year performance. The normalized earnings are intended to give a representation of our performance had Xylem been a stand-alone company in 2011.


U.S. reach in dewatering rental and service, and grows our presence in industrial markets. And our two other recent acquisitions, YSI and MJK Automation, both continue to perform well and help establish our Analytics business as a long-term growth platform.”

McClain said the company continues to move forward with restructuring and realignment initiatives, and now foresees approximately $20 million in aggregated costs during 2012 to position the business for future growth. The company maintains its outlook for full-year 2012 revenue of $3.8 billion, and has revised the mid-point of its 2012 earnings guidance to $1.76 from $1.77 per share to reflect the $0.01 per share dilutive impact of the Heartland Pump acquisition.

Business Segment Results

Water Infrastructure

Xylem’s Water Infrastructure businesses provide equipment and services focused on the transport, treatment and testing of water and wastewater in the public utility and industrial markets.

 

   

Third quarter 2012 segment revenue was $595 million, up 7 percent in constant currencies, and up 2 percent as reported, with growth in public utility activity in all regions more than offsetting weakness in industrial.

 

   

Third quarter adjusted segment operating margin was 15.0 percent. Stand-alone costs negatively impacted operating margin 50 basis points for the third quarter of 2012.

Applied Water

Xylem’s Applied Water businesses provide equipment and services in the residential and commercial building services, general industrial and agricultural markets.

 

   

Third quarter 2012 segment revenue was $350 million, down 2 percent in constant currencies, and 5 percent as reported, reflecting comparison to a particularly strong third quarter 2011, and ongoing weakness in commercial building services.

 

   

Third quarter adjusted segment operating margin was 12.6 percent. Stand-alone costs negatively impacted operating margin 60 basis points for the third quarter of 2012.

More detail available

Supplemental information on Xylem’s third quarter earnings and reconciliations for certain non-GAAP items is posted at investors.xyleminc.com.

About Xylem

Xylem (NYSE: XYL) is a leading global water technology provider, enabling customers to transport, treat, test and efficiently use water in public utility, residential and commercial building services, industrial and agricultural settings. The company does business in more than 150 countries through a number of market-leading product brands, and its people bring broad

 

2


applications expertise with a strong focus on finding local solutions to the world’s most challenging water and wastewater problems. Launched in 2011 from the spinoff of the water-related businesses of ITT Corporation, Xylem is headquartered in White Plains, N.Y., with 2011 annual revenues of $3.8 billion and 12,500 employees worldwide. In 2012, Xylem was named to the Dow Jones Sustainability World Index for advancing sustainable business practices and solutions worldwide.

The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all — that which occurs in nature. For more information, please visit us at www.xyleminc.com.

Forward-Looking Statements

This document contains information that may constitute “forward-looking statements.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.

These forward-looking statements include, but are not limited to, statements about the separation of Xylem Inc. (the “Company”) from ITT Corporation, the terms and the effect of the separation, the nature and impact of the separation, capitalization of the Company, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals, and any discussion of future operating or financial performance. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to orders, sales, operating margins and earnings per share growth, and statements expressing general views about future operating results — are forward-looking statements.

Caution should be taken not to place undue reliance on any such forward-looking statements because they involve risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the Company’s historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those set forth in Item 1A in our Annual Report on Form 10-K, and those described from time to time in subsequent reports filed with the Securities and Exchange Commission.

###

 

3


XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED AND COMBINED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

 

     Three Months      Nine Months  

For the periods ended September 30,

   2012      2011      2012      2011  

Revenue

   $ 931       $ 939       $ 2,822       $ 2,800   

Cost of revenue

     557         574         1,702         1,719   
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross profit

     374         365         1,120         1,081   

Selling, general and administrative expenses

     231         215         682         643   

Research and development expenses

     24         23         80         73   

Restructuring and asset impairment charges, net

     4         2         4         2   

Separation costs

     4         46         15         67   
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income

     111         79         339         296   

Interest expense

     14         1         41         2   

Other non-operating income, net

     3         4         1         5   
  

 

 

    

 

 

    

 

 

    

 

 

 

Income before taxes

     100         82         299         299   

Income tax expense

     28         5         75         72   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 72       $ 77       $ 224       $ 227   
  

 

 

    

 

 

    

 

 

    

 

 

 

Earnings per share:

           

Basic

   $ 0.39       $ 0.42       $ $1.20       $ 1.23   

Diluted

   $ 0.38       $ 0.42       $ $1.20       $ 1.23   

Weighted average number of shares:

           

Basic

     185.9         184.6         185.7         184.6   

Diluted

     186.3         184.6         186.2         184.6   

Dividends declared per share

   $ 0.1012       $ —         $ 0.3036       $ —     


XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except per share amounts)

 

     September 30,     December 31,  
     2012     2011  
     (Unaudited)        

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 424      $ 318   

Receivables, less allowances for discounts and doubtful accounts of $33 and $37 in 2012 and 2011, respectively

     801        756   

Inventories, net

     467        426   

Prepaid and other current assets

     106        97   

Deferred income tax assets

     36        45   
  

 

 

   

 

 

 

Total current assets

     1,834        1,642   

Property, plant and equipment, net

     464        463   

Goodwill

     1,621        1,610   

Other intangible assets, net

     485        505   

Other non-current assets

     192        173   
  

 

 

   

 

 

 

Total assets

   $ 4,596      $ 4,393   
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

   $ 316      $ 322   

Accrued and other current liabilities

     456        490   

Short-term borrowings and current maturities of long-term debt

     13        5   
  

 

 

   

 

 

 

Total current liabilities

     785        817   

Long-term debt

     1,199        1,201   

Accrued postretirement benefits

     319        316   

Deferred income tax liability

     170        165   

Other non-current accrued liabilities

     69        67   
  

 

 

   

 

 

 

Total liabilities

     2,542        2,566   
  

 

 

   

 

 

 

Commitments and contingencies

Stockholders’ equity:

    

Common Stock – authorized 750.0 shares, par value $0.01 per share:

    

Issued 186.0 shares and 184.6 shares in 2012 and 2011, respectively

     2        2   

Capital in excess of par value

     1,699        1,663   

Retained earnings

     206        40   

Treasury stock – at cost 0.2 shares and 0 shares in 2012 and 2011, respectively

     (6     —     

Accumulated other comprehensive income

     153        122   
  

 

 

   

 

 

 

Total stockholders’ equity

     2,054        1,827   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 4,596      $ 4,393   
  

 

 

   

 

 

 


XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

 

For the nine months ended September 30,

   2012     2011  

Operating Activities

    

Net income

   $ 224      $ 227   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     103        104   

Share-based compensation

     16        7   

Non-cash separation costs

     —          8   

Restructuring and asset impairment charges

     4        2   

Payments for restructuring

     —          (7

Changes in assets and liabilities (net of acquisitions):

    

Changes in receivables

     (33     (58

Changes in inventories

     (33     (40

Changes in accounts payable

     (7     (31

Changes in accrued liabilities

     (30     14   

Changes in accrued taxes

     1        4   

Net changes in other assets and liabilities

     (14     18   

Other, net

     (1     4   
  

 

 

   

 

 

 

Net Cash - Operating activities

     230        252   
  

 

 

   

 

 

 

Investing Activities

    

Capital expenditures

     (81     (79

Acquisitions, net of cash required

     (12     (309

Proceeds from the sale of property, plant and equipment

     4        9   

Other, net

     —          2   
  

 

 

   

 

 

 

Net Cash - Investing activities

     (89     (377
  

 

 

   

 

 

 

Financing Activities

    

Net transfer to former parent

     (9     (1,012

Issuance of short-term debt

     12        5   

Issuance of senior notes, net of discount

     —          1,189   

Principal payments of debt and capital lease obligations

     (6     —     

Purchase of common stock

     (4     —     

Proceeds from exercise of employee stock options

     22        —     

Dividends paid

     (56     —     
  

 

 

   

 

 

 

Net Cash - Financing activities

     (41     182   
  

 

 

   

 

 

 

Effect of exchange rate changes on cash

     6        (4
  

 

 

   

 

 

 

Net change in cash and cash equivalents

     106        53   

Cash and cash equivalents at beginning of year

     318        131   
  

 

 

   

 

 

 

Cash and cash equivalents at end of year

   $ 424      $ 184   
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

    

Cash paid during the period for:

    

Interest

   $ 38      $ —     

Income taxes (net of refunds received)

   $ 76      $ 37   


Xylem Inc. Non-GAAP Measures

Management views key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, free cash flow, working capital, and backlog, among others. In addition, we consider certain measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operations as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

“Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of foreign currency fluctuations, intercompany transactions, and contributions from acquisitions and divestitures. Divestitures include sales of portions of our business that did not meet the criteria for classification as a discontinued operation or insignificant portions of our business that we did not classify as a discontinued operation. The period-over-period change resulting from foreign currency fluctuations assumes no change in exchange rates from the prior period.

“Constant currency” defined as financial results adjusted for currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation, amortization expense, and share-based compensation. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude for non-recurring separation costs associated with the Xylem spin-off from ITT Corporation as well as non-recurring restructuring and realignment costs.

“Adjusted Operating Income”, “Adjusted Segment Operating Income”, and “Adjusted EPS” defined as operating income and earnings per share, adjusted to exclude non-recurring separation costs associated with the Xylem spin-off from ITT Corporation, non-recurring restructuring and realignment costs and tax-related special items.

“Normalized EPS” defined as adjusted earnings per share, as well as adjustments to reflect the incremental current period amount of interest expense and stand alone costs in the prior comparable period.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flows does not consider non-discretionary cash payments, such as debt.


Xylem Inc. Non-GAAP Reconciliation

Reported vs. Organic & Constant Currency Order Growth

($ Millions)

 

    (As Reported - GAAP)     (As Adjusted - Organic)     Constant
Currency
 
          (A)     (B)           (C)     (D)     (E)     (F) = B+C+D+E     (G) = F/A     (H) = (B +
D) / A
 
    Orders     Orders     Change
2012 v.
2011
    % Change
2012 v.
2011
    Acquisitions /
Divestitures
    FX
Contribution
    Eliminations     Change
Adj. 2012 v.
2011
    % Change
Adj. 2012
v. 2011
       
    2012        2011                   

Nine Months Ended September 30

  

       

Xylem Inc.

    2,856        2,942        (86     -2.9     (88     108        —          (66     -2.2     0.7

Water infrastructure

    1,819        1,865        (46     -2.5     (88     82        —          (52     -2.8     1.9

Applied Water

    1,086        1,122        (36     -3.2     —          30        (8     (14     -1.2     -0.5

Quarter Ended September 30, 2012

  

       

Xylem Inc.

    882        966        (84     -8.7     (21     39        —          (66     -6.8     -4.7

Water infrastructure

    564        621        (57     -9.2     (21     29        —          (49     -7.9     -4.5

Applied Water

    334        358        (24     -6.7     —          12        (5     (17     -4.7     -3.4

Quarter Ended June 30

  

       

Xylem Inc.

    970        998        (28     -2.8     (30     51        —          (7     -0.7     2.3

Water infrastructure

    617        632        (15     -2.4     (30     40        —          (5     -0.8     4.0

Applied Water

    370        383        (13     -3.4     —          13        (2     (2     -0.5     0.0

Quarter Ended March 31

  

       

Xylem Inc.

    1,004        978        26        2.7     (37     18        —          7        0.7     4.5

Water infrastructure

    638        612        26        4.2     (37     13        —          2        0.3     6.4

Applied Water

    382        381        1        0.3     —          5        (1     5        1.3     1.6

Note: Due to rounding the sum of segment amounts may not agree to Xylem totals.


Xylem Inc. Non-GAAP Reconciliation

Reported vs. Organic & Constant Currency Revenue

($ Millions)

 

    (As Reported - GAAP)     (As Adjusted - Organic)     Constant
Currency
 
          (A)     (B)           (C)     (D)     (E)     (F) = B+C+D+E     (G) = F/A     (H) = (B +
D) / A
 
    Revenue     Revenue     Change
2012 v.
2011
    % Change
2012 v.
2011
    Acquisitions /
Divestitures
    FX
Contribution
    Eliminations     Change Adj.
2012 v. 2011
    % Change
Adj. 2012
v. 2011
       
    2012     2011                                                  

Nine Months Ended September 30

  

       

Xylem Inc.

    2,822        2,800        22        0.8     (87     101        —          36        1.3     4.4

Water infrastructure

    1,788        1,737        51        2.9     (87     75        —          39        2.2     7.3

Applied Water

    1,078        1,108        (30     -2.7     —          30        (3     (3     -0.3     0.0

Quarter Ended September 30, 2012

  

       

Xylem Inc.

    931        939        (8     -0.9     (21     38        —          9        1.0     3.2

Water infrastructure

    595        584        11        1.9     (21     28        —          18        3.1     6.7

Applied Water

    350        368        (18     -4.9     —          12        (2     (8     -2.2     -1.6

Quarter Ended June 30

  

       

Xylem Inc.

    966        971        (5     -0.5     (32     49        —          12        1.2     4.5

Water infrastructure

    609        602        7        1.2     (32     37        (1     11        1.8     7.3

Applied Water

    373        385        (12     -3.1     —          13        (1     —          0.0     0.3

Quarter Ended March 31

  

       

Xylem Inc.

    925        890        35        3.9     (34     14        —          15        1.7     5.5

Water infrastructure

    584        551        33        6.0     (34     10        1        10        1.8     7.8

Applied Water

    355        355        —          0.0     —          5        —          5        1.4     1.4

Note: Due to rounding the sum of segment amounts may not agree to Xylem totals.


Xylem Inc. Non-GAAP Reconciliation

Adjusted Diluted EPS

For The Three and Nine Months Ended September 30, 2012 & 2011

($ Millions, except per share amounts)

 

     Q1 2012      Q2 2012     Q3 2012     YTD 2012  

Net Income

     63         89        72        224   

Separation Costs, Net of Tax

     4         4        3        11   

Restructuring & Realignment, Net of Tax

     —           —          4        4   
  

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted Net Income before Special Tax Items

     67         93        79        239   
  

 

 

    

 

 

   

 

 

   

 

 

 

Special Tax Items

     —           (1     4        3   
  

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted Net Income

     67         92        83        242   
  

 

 

    

 

 

   

 

 

   

 

 

 

Diluted Earnings per Share

   $ 0.34       $ 0.48      $ 0.38      $ 1.20   

Separation Costs per Share

   $ 0.02       $ 0.02      $ 0.02      $ 0.06   

Restructuring & Realignment Costs per Share

   $ 0.00       $ 0.00      $ 0.02      $ 0.02   
  

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted Diluted EPS before Special Tax Items

   $ 0.36       $ 0.50      $ 0.42      $ 1.28   

Special Tax Items per Share

   $ 0.00       $ (0.01   $ 0.02      $ 0.01   
  

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted Diluted EPS

   $ 0.36       $ 0.49      $ 0.44      $ 1.29   
  

 

 

    

 

 

   

 

 

   

 

 

 
     Q1 2011      Q2 2011     Q3 2011     YTD 2011  

Net Income

     78         72        77        227   

Separation Costs, Net of Tax

     2         27        25        54   
  

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted Net Income before Special Tax Items

     80         99        102        281   
  

 

 

    

 

 

   

 

 

   

 

 

 

Special Tax Items

     —           4        (1     3   
  

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted Net Income

     80         103        101        284   
  

 

 

    

 

 

   

 

 

   

 

 

 

Diluted Earnings per Share

   $ 0.42       $ 0.39      $ 0.42      $ 1.23   

Separation Costs per Share

   $ 0.01       $ 0.15      $ 0.13      $ 0.29   
  

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted Diluted EPS before Special Tax Items

   $ 0.43       $ 0.54      $ 0.55      $ 1.52   

Special Tax Items per Share

   $ 0.00       $ 0.02      $ (0.01   $ 0.01   
  

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted Diluted EPS

   $ 0.43       $ 0.56      $ 0.54      $ 1.53   
  

 

 

    

 

 

   

 

 

   

 

 

 


Xylem Inc. Non-GAAP Reconciliation

Adjusted Operating Income

($ Millions)

 

     Q3     YTD  
     ‘12     ‘11     ‘12     ‘11  

Total Revenue

        

• Total Xylem

     931        939        2,822        2,800   

• Water Infrastructure

     595        584        1,788        1,737   

• Applied Water

     350        368        1,078        1,108   

Operating Income

        

• Total Xylem

     111        79        339        296   

• Water Infrastructure

     85        87        253        245   

• Applied Water

     43        37        135        133   

Operating Margin

        

• Total Xylem

     11.9     8.4     12.0     10.6

• Water Infrastructure

     14.3     14.9     14.1     14.1

• Applied Water

     12.3     10.0     12.5     12.0

Separation Costs

        

• Total Xylem

     4        46        15        67   

• Water Infrastructure

     —          8        3        10   

• Applied Water

     1        9        2        9   

Restructuring & Realignment Costs

        

• Total Xylem

     5        —          5        —     

• Water Infrastructure

     4        —          4        —     

• Applied Water

     —          —          —          —     

Adjusted Operating Income*

        

• Total Xylem

     120        125        359        363   

• Water Infrastructure

     89        95        260        255   

• Applied Water

     44        46        137        142   

Adjusted Operating Margin*

        

• Total Xylem

     12.9     13.3     12.7     13.0

• Water Infrastructure

     15.0     16.3     14.5     14.7

• Applied Water

     12.6     12.5     12.7     12.8

 

* Adjusted Operating Income excludes non-recurring separation, restructuring & realignment costs

 


Xylem Inc. Non-GAAP Reconciliation

Normalized and Adjusted Diluted EPS

($ Millions, except per share amounts)

 

     Q3 2011     Q3 2012  
     As
Reported
    Adjustments           Adjusted     Adjustments           Normalized     As
Reported
    Adjustments            Adjusted  

Total Revenue

     939            939            939        931             931   

Operating Income

     79        46        a        125        (8 )     c        111        111        9        a         120   

Operating Margin

     8.4         13.3         12.5     11.9          12.9

Interest Expense

     (1         (1     (13     d        (14     (14          (14

Other Non-Operating Income (Expense)

     4            4            4        3             3   
  

 

 

   

 

 

     

 

 

   

 

 

     

 

 

   

 

 

   

 

 

      

 

 

 

Income before Taxes

     82        46          128        (21       107        100        9           109   
  

 

 

   

 

 

     

 

 

   

 

 

     

 

 

          

Provision for Income Taxes

     (5     (22 )     b        (27     4        e        (23     (28     2        b         (26
  

 

 

   

 

 

     

 

 

   

 

 

     

 

 

   

 

 

   

 

 

      

 

 

 

Net Income

     77        24          101        (17       84        72        11           83   
  

 

 

   

 

 

     

 

 

   

 

 

     

 

 

   

 

 

   

 

 

      

 

 

 

Diluted Shares

     184.6                  184.6        186.3             186.3   

Diluted EPS

   $ 0.42      $ 0.12        $ 0.54      $ (0.09     $ 0.45      $ 0.38      $ 0.06         $ 0.44   

 

a One time separation, restructuring & realignment costs
b Tax impact of one time separation costs and special tax items
c Incremental stand alone costs incurred in 2012
d Incremental interest expense on long-term debt entered into in conjunction with the spin
e Tax impact of incremental interest expense and stand alone costs incurred in 2012

 


Xylem Inc. Non-GAAP Reconciliation

Net Cash - Operating Activities vs. Free Cash Flow

For The Nine Months Ended September 30, 2012 & 2011

($ Millions)

 

     Nine Months Ended  
     2012     2011  

Net Cash - Operating Activities

     230        252   

Capital Expenditures

     (81     (79
  

 

 

   

 

 

 

Free Cash Flow, including separation costs

     149        173   

Cash Paid for Separation Costs (incl. Capex)

     22        62   
  

 

 

   

 

 

 

Free Cash Flow, excluding separation costs

     171        235   
  

 

 

   

 

 

 

Net Income

     224        227   

Separation Costs, net of tax (incl. tax friction)

     11        54   
  

 

 

   

 

 

 

Adjusted Net Income

     235        281   
  

 

 

   

 

 

 

Free Cash Flow Conversion

     73     84
  

 

 

   

 

 

 


Xylem Inc. Non-GAAP Reconciliation

Guidance

($ Millions, except per share amounts)

 

                                                 Illustration of Mid Point Guidance  

2012 Guidance

                                                                     
     FY ‘11     FY ‘12  
     As Reported     Adjustments            Adjusted     Adjustments            Normalized     As Projected     Adjustments            Adjusted  

Total Revenue

     3,803             3,803             3,803        3,800             3,800   

Segment Operating Income

     503        29        a         532        (10     d         522        516        25        h,i         541   

Segment Operating Margin

     13.2          14.0          13.7     13.6          14.2

Corporate Expense

     108        (58 )     b         50        18        e         68        68        (15 )     h         53   
  

 

 

   

 

 

      

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Operating Income

     395        87           482        (28        454        448        40           488   
  

 

 

   

 

 

      

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Operating Margin

     10.4          12.7          11.9     11.8          12.8

Interest Expense

     (17          (17     (39 )     f         (56     (54          (54

Other Non-Operating Income (Expense)

     5             5             5        (1          (1
  

 

 

        

 

 

   

 

 

      

 

 

   

 

 

        

 

 

 

Income before Taxes

     383        87           470        (67        403        393        40           433   
  

 

 

   

 

 

      

 

 

   

 

 

      

 

 

          

Provision for Income Taxes

     (104     (8     c         (112     16        g         (96     (99     (7     j         (106
  

 

 

   

 

 

      

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Net Income

     279        79           358        (51        307        294        33           327   
  

 

 

   

 

 

      

 

 

   

 

 

      

 

 

   

 

 

   

 

 

      

 

 

 

Diluted Shares

     185.3                    185.3        186.2             186.2   

Diluted EPS

   $ 1.50      $ 0.43         $ 1.93      $ (0.27        1.66        1.58        0.18           1.76   

 

a One time separation costs incurred at the segment level
b One time separation costs incurred at the corporate level
c Net tax impact of above items, plus the addition of 2011 special tax items
d Incremental stand alone costs to be incurred in 2012 at the segment level ($10M)
e Incremental stand alone costs to be incurred in 2012 at the corporate level ($18M)
f Incremental interest expense on long-term debt to be incurred in 2012
g Tax impact of incremental interest expense and stand alone costs to be incurred in 2012
h Expected one time separation costs of $5M and $15M to be incurred at the segments and headquarters, respectively.
i Restructuring & realignment costs of $20M to be incurred at the segments.
j Tax impact of one time separation, restructuring & realignment costs expected to be incurred in 2012 and tax special items realized through Q3 2012.


Xylem Inc. Non-GAAP Reconciliation

Adjusted Operating Income

($ Millions)

 

                             Mid Point
Guidance
 
     2008     2009     2010     2011     2012E  

Revenue

     3,291        2,849        3,202        3,803        3,800   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating Income

     315        276        388        395        448   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating Margin

     9.6     9.7     12.1     10.4     11.8

Restructuring & Realignment

     41        31        15        —          20   

Separation Costs

     —          —          —          87        20   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted Operating Income

     356        307        403        482        488   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted Operating Margin

     10.8     10.8     12.6     12.7     12.8

Stand alone Costs

     —          —          —          5        28   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adj. Operating Income, excl. Stand alone Costs

     356        307        403        487        516   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted Operating Margin, excl. Stand alone Costs

     10.8     10.8     12.6     12.8     13.6